Decoding 7 Analyst Evaluations For Alkermes
Portfolio Pulse from Benzinga Insights
Alkermes (NASDAQ:ALKS) has been analyzed by 7 analysts, showing a range of perspectives from bullish to bearish. The average 12-month price target is $40.29, with a high of $48.00 and a low of $31.00. Recent analyst actions include maintaining, raising, and lowering ratings, reflecting their views on Alkermes' market standing. Despite revenue challenges, Alkermes shows strong financial health with high net margins, ROE, and ROA.
October 10, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Alkermes has received mixed analyst ratings, with a 12-month price target average of $40.29. Despite a revenue decline, the company shows strong financial health with high net margins and ROE.
The mixed analyst ratings suggest a neutral short-term impact on ALKS stock. The increase in average price target indicates some positive sentiment, but the revenue decline tempers this. Strong financial health metrics like high net margins and ROE provide a solid foundation, but the immediate revenue challenges may offset potential gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100